Tag: Emerald Health Therapeutics

October 18, 2019

Cannabis Weekly Round-Up: Legalization 2.0 Gets to Canada

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
October 15, 2019

Emerald Health Disputes C$7 Million Charge from Pure Sunfarms

The discord is centered around a “price deficiency obligation” invoice that Pure Sunfarms sent Emerald for approximately C$7 million. Emerald...
October 15, 2019

Avricore Health Appoints CEO, President and Advisors

Avricore Health Inc. Board of Directors announces the appointment of Hector Bremner as CEO and Bob Rai as President effective...
October 2, 2019

Canada’s Cannabis Sector Adds C$8.26 Billion to National GDP

The marijuana industry's contribution to Canada's GDP has increased steadily from the C$7.02 billion seen last October after legalization.
September 26, 2019

6 Cannabis Stocks Represented on Inaugural TSX30 List

The first ever TSX30 list, which shows the top-performing stocks for the past three years, includes a variety of companies...
August 20, 2019

Avricore Health Corporate Update and Private Placement Extension

Avricore Health Inc. (TSXV:AVCR, OTC:AVCRF) ("Avricore Health" or the "Company") is pleased to provide an update on the significant progress the...
July 29, 2019

Cannabis Companies: Stocks on the TSXV

The number of cannabis companies listed on the TSXV is growing quickly. Here's a list of current stocks on the...